EUVIMEDEUVIMED entdecken
Crossref

Phytochemical Profiling by HPLC‐ESI‐MS/MS and In Vitro Investigation of the Antidiabetic Activity of Cassia bakeriana Bark Extract and Fractions

Diego G Prado iD, Allisson B Justino iD, Tiara da C Silva iD, Sérgio A L de Morais iD, Mário M Martins iD, Paula de S Santos iD, Luís C S Cunha iD, Raquel M F de Sousa iD, Francisco J T de Aquino iD, Foued S Espindola iD, Alberto de Oliveira iD

Journal of Mass Spectrometry · 2024

DOI: 10.1002/jms.5099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Mass Spectrometry, 2024. Verfasst von Diego G Prado und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nucleus of Research in Natural Products, Institute of Chemistry, Federal University of Uberlândia, Uberlândia, Brazil. Hauptthemen laut MEDLINE: Plant Extracts, Cassia, Plant Bark, Hypoglycemic Agents. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Institutos Nacionais de Ciência e Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus is a global health problem, placing patients at a higher risk of developing cardiovascular diseases and cancer. This study investigates the antidiabetic potential of Cassia bakeriana bark extracts and fractions. We evaluate their ability to inhibit α‐amylase and α‐glucosidase enzymes and advanced glycation end‐products (AGEs). The antioxidant potential was also examined. Extracts were prepared through maceration with hexane (HE) and ethanol (EE), and the fractions were obtained via liquid–liquid extraction from EE. Anti‐enzymatic, anti‐glycation, antioxidant, and cytotoxic assays were conducted in 96‐well plates using different concentrations of samples to determine the half‐maximal inhibitory concentration (IC 50 ). Active samples were further analyzed using HPLC‐(−)‐ESI‐MS/MS. The ethyl acetate fraction (EAF) demonstrated a high percentage of α‐amylase inhibition (94.0%) with a promising IC 50 value of 1.05 μg mL −1 . Additionally, EAF displayed 61.5% inhibition of α‐glucosidase, with an IC 50 value of 537 μg mL −1 . The EE, EAF, and n ‐butanol fraction (BF) exhibited strong anti‐glycation capacities. Furthermore, the EE, EAF, BF, and dichloromethane fractions showed promising antioxidant activity using the DPPH and ORAC methodologies. Cytotoxic activity was also evaluated with Vero cells, revealing no adverse effects on cell viability (CC 50 > 512.0 μg mL −1 ). Active samples predominantly comprised proanthocyanidins, flavonoids, and anthraquinone, representing the main constituents of C. bakeriana bark. This study provides the first assessment of the antidiabetic potential of C. bakeriana bark and a comprehensive analysis of the chemical composition of its active extracts and fractions, offering hope for future treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsCassiaPlant BarkHypoglycemic AgentsTandem Mass SpectrometrySpectrometry, Mass, Electrospray Ionizationalpha-AmylasesAntioxidantsChromatography, High Pressure LiquidAnimalsPhytochemicalsGlycoside Hydrolase Inhibitorsalpha-GlucosidasesGlycation End Products, AdvancedVero CellsChlorocebus aethiopsCell SurvivalHumans

Stichwörter der Autor:innen

Cassia bakerianaantioxidantsanti‐enzymaticglycationphenolic compounds

Substanzen

Plant ExtractsHypoglycemic Agentsalpha-AmylasesAntioxidantsPhytochemicalsGlycoside Hydrolase Inhibitorsalpha-GlucosidasesGlycation End Products, Advanced

Autor:innen und Institutionen

  • Nucleus of Research in Natural Products, Institute of Chemistry, Federal University of Uberlândia, Uberlândia, Brazil.
  • Laboratory of Biochemistry and Molecular Biology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, MG, Brazil.
  • Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, MG, Brazil.
  • Bioprospecting Center for Natural Products, Chemistry Department, Federal Institute of Triângulo Mineiro, Uberaba, MG, Brazil.

ORCID-Profile: Diego G Prado, Allisson B Justino, Tiara da C Silva, Sérgio A L de Morais, Mário M Martins, Paula de S Santos, Luís C S Cunha, Raquel M F de Sousa, Francisco J T de Aquino, Foued S Espindola, Alberto de Oliveira

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Institutos Nacionais de Ciência e Tecnologia
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Prado, D. G., Justino, A. B., Silva, T. D. C., de Morais, S. A. L., Martins, M. M., Santos, P. S., Cunha, L. C. S., de Sousa, R. M. F., de Aquino, F. J. T., Espindola, F. S., & de Oliveira, A. (2024). Phytochemical Profiling by HPLC‐ESI‐MS/MS and In Vitro Investigation of the Antidiabetic Activity of Cassia bakeriana Bark Extract and Fractions. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.5099

Vancouver

Prado DG, Justino AB, Silva TDC, de Morais SAL, Martins MM, Santos PS, et al. Phytochemical Profiling by HPLC‐ESI‐MS/MS and In Vitro Investigation of the Antidiabetic Activity of Cassia bakeriana Bark Extract and Fractions. Journal of Mass Spectrometry. 2024. doi:10.1002/jms.5099

BibTeX
@article{Prado2024,
  author = {Prado, Diego G and Justino, Allisson B and Silva, Tiara da C and de Morais, Sérgio A L and Martins, Mário M and Santos, Paula de S and Cunha, Luís C S and de Sousa, Raquel M F and de Aquino, Francisco J T and Espindola, Foued S and de Oliveira, Alberto},
  title = {Phytochemical Profiling by HPLC‐ESI‐MS/MS and In Vitro Investigation of the Antidiabetic Activity of Cassia bakeriana Bark Extract and Fractions},
  journal = {Journal of Mass Spectrometry},
  year = {2024},
  doi = {10.1002/jms.5099}
}
Kostenlos starten →